These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 14476151)
1. [On bradykinin, kallidin, and various analogous kinds of biologically active polypeptides]. MORIYA H Tanpakushitsu Kakusan Koso; 1962 Jun; 7():382-6. PubMed ID: 14476151 [No Abstract] [Full Text] [Related]
2. [STRUCTURE AND FUNCTION OF THE BIOLOGICALLY ACTIVE PEPTIDES: BRADYKININ, KALLIDIN, ANGIOTENSIN AND SUBSTANCE P]. MICHAUD J Presse Med (1893); 1964 Oct; 72():2693-8. PubMed ID: 14226744 [No Abstract] [Full Text] [Related]
8. [APNEA AFTER BRADYKININ AND KALLIDIN]. GJURIS V; HEICKE B; WESTERMANN E Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1964 Aug; 248():540-51. PubMed ID: 14316389 [No Abstract] [Full Text] [Related]
9. [Pharmacological differences between bradykinin and kallidin]. HOLTZ P; BARCK S; HEICKE B Arch Int Pharmacodyn Ther; 1962 Nov; 140():79-83. PubMed ID: 13961475 [No Abstract] [Full Text] [Related]
10. [ON THE EFFECT OF BRADYKININ, KALLIDIN AND ELEDOISIN ON THE CAT AND RABBIT INTESTINE IN SITU]. WINKLER H; BAUER G; GMEINER R Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1965 Apr; 250():459-68. PubMed ID: 14336580 [No Abstract] [Full Text] [Related]
11. Close similarity and minor differences between bradykinin and kallidin. VAN ARMAN CG; MILLER LM J Pharmacol Exp Ther; 1961 Mar; 131():366-72. PubMed ID: 13779854 [No Abstract] [Full Text] [Related]
12. ENDOGENEOUS MECHANISMS IN INCREASED VASCULAR PERMEABILITY IN INFLAMMATION. HAYASHI H Acta Pathol Jpn; 1963 Oct; 13():213-5. PubMed ID: 14195178 [No Abstract] [Full Text] [Related]
13. BLOCKING OF THE IN VIVO EFFECTS OF BRADYKININ AND KALLIDIN WITH CARBOXYPEPTIDASE B. ERDOES EG; WOHLER JR; LEVINE MI J Pharmacol Exp Ther; 1963 Dec; 142():327-34. PubMed ID: 14098329 [No Abstract] [Full Text] [Related]
14. [Stimulation of respiration by bradykinin and kallidin]. GJURIS V; HEICKE B; HOLTZ P; WESTERMANN E Experientia; 1962 Aug; 18():385. PubMed ID: 13899062 [No Abstract] [Full Text] [Related]
15. A comparison in conscious and anaesthetized dogs of the effect on blood pressure of bradykinin, kallidin, eledoisin and kallikrein. Pearson L; Lang WJ Eur J Pharmacol; 1967 Nov; 2(2):83-7. PubMed ID: 5583434 [No Abstract] [Full Text] [Related]
16. The synthesis of a biologically active decapeptide having the structure proposed for kallidin II. NICOLAIDES ED; DEWALD HA; McCARTHY DA Biochem Biophys Res Commun; 1961 Nov; 6():210-2. PubMed ID: 14479512 [No Abstract] [Full Text] [Related]
17. ENDOGENEOUS PERMEABILITY FACTORS AND THEIR INHIBITORS AFFECTING VASCULAR PERMEABILITY IN CUTANEOUS ARTHUS REACTIONS AND THERMAL INJURY. HAYASHI H; YOSHINAGA M; KOONO M; MIYOSHI H; MATSUMURA M Br J Exp Pathol; 1964 Aug; 45(4):419-35. PubMed ID: 14203198 [No Abstract] [Full Text] [Related]
18. Kallikrein, kallidin, kallikrein inhibitors. WERLE E; TRAUTSCHOLD I Ann N Y Acad Sci; 1963 Feb; 104():117-29. PubMed ID: 14000004 [No Abstract] [Full Text] [Related]
19. [The role of some polypeptides and protein derivatives in inflammation]. Popescu E Stud Cercet Med Interna; 1969; 10(1):29-37. PubMed ID: 4241956 [No Abstract] [Full Text] [Related]
20. An enzyme in human blood plasma that inactivates bradykinin and kallidins. ERDOS EG; SLOANE EM Biochem Pharmacol; 1962 Jul; 11():585-92. PubMed ID: 13890520 [No Abstract] [Full Text] [Related] [Next] [New Search]